| Literature DB >> 27445630 |
Jordana A Waxman1, Rebecca R Pillai Riddell2, Paula Tablon1, Louis A Schmidt3, Angelina Pinhasov1.
Abstract
Background. Cardiovascular indices of pain are pervasive in the hospital setting. However, no prospective research has examined the development of cardiac responses to acutely painful procedures in the first year of life. Objectives. Our main goal was to synthesize existing evidence regarding the development of cardiovascular responses to acutely painful medical procedures over the first year of life in preterm and term born infants. Methods. A systematic search retrieved 6994 articles to review against inclusion criteria. A total of 41 studies were included in the review. Results. In response to acutely painful procedures, most infants had an increase in mean heart rate (HR) that varied in magnitude both across and within gestational and postnatal ages. Research in the area of HR variability has been inconsistent, limiting conclusions. Conclusions. Longitudinal research is needed to further understand the inherent variability of cardiovascular pain responses across and within gestational and postnatal ages and the causes for the variability.Entities:
Mesh:
Year: 2016 PMID: 27445630 PMCID: PMC4904608 DOI: 10.1155/2016/8458696
Source DB: PubMed Journal: Pain Res Manag ISSN: 1203-6765 Impact factor: 3.037
Figure 1Included study flow chart following PRISMA guidelines.
Study characteristics.
| Study |
| Country | Gestational age | Postnatal age | Acute pain procedure | Cardiovascular measure | Study design | Quality score∧ |
|---|---|---|---|---|---|---|---|---|
| Abad et al. [ | 15 | Spain | 37–42 | <4 days | Venipuncture | Mean HR | CS; randomized trial | 17 |
| Altun-Köroğlu et al. [ | 25 | Turkey | 37–41 | 4–8 days | Heel stick | Maximum HR | CS; double-blind, placebo-controlled trial | 13 |
| Bilgen et al. [ | 34 | Turkey | 37–42 | 1–9 days | Heel stick | HR change (%) | CS; randomized trial | 14 |
| Bucher et al. [ | 20 | Switzerland | 37–41 | 4 days | Heel stick | HR change (bpm) | CS; randomized trial | 14 |
| Campos [ | 20 | United States | 37–42 | 2 days | Heel stick | Mean HR | CS; randomized trial | 15 |
| Cong et al. [ | 28 | United States | 28–32 | <14 days | Heel stick | HR increase, HRV | CS; randomized cross-over trial | 17 |
| Cong et al. [ | 14 | United States | 30–32 | <9 days | Heel stick | Mean HR, HRV | CS; randomized cross-over trial | 17 |
| Craig et al. [ | 56 | Canada | 25–27, 28–30, 31–33, 34–36, and 37–42 | <8 days | Heel stick | Mean HR | CS; observational | 17 |
| de Jesus et al. [ | 41 | Brazil | 37–41 | <2 days | Heel stick | HRV | CS; observational | 15 |
| de Oliveira et al. [ | 36 | Brazil | 37–41 | <2 days | Heel stick | Maximum HR, HRV | CS; observational | 14 |
| Gormally et al. [ | 21 | Canada | 37–42 | 2 days | Heel stick | Mean HR, HRV | CS; randomized controlled trial | 15 |
| Goubet et al. [ | 14 | United States | 28–32 | 4 days, 21 days | Heel stick | HR change | C; observational | 13 |
| Gray et al. [ | 15 | United States | 37–42 | <3 days | Heel stick | Mean HR | CS; randomized controlled trial | 17 |
| Greenberg [ | 21 | United States | 37–42 | <1 day | Heel stick | Mean HRV | CS; randomized trial | 13 |
| Grunau et al. [ | 138 | Canada | ≤28, 29–32, and 38–41 | 4 months | Immunization | Mean HR | C; observational | 16 |
| Haouari et al. [ | 15 | England | 37–42 | <6 days | Heel stick | HR change (%) | CS; double-blind, placebo controlled trial | 15 |
| Jatana et al. [ | 25 | India | 37–42 | <7 days | Heel stick | HR change (bpm) | CS; randomized trial | 10 |
| Johnston et al. [ | 20 | Canada | 32–35 | <10 days | Heel stick | Mean HR | CS; randomized cross-over trial | 15 |
| Johnston et al. [ | 89 | Canada | 27, 32 | 4 days, 5 weeks | Heel stick | Mean HR | CS; observational | 15 |
| Kostandy et al. [ | 19 | United States | 37–42 | 1 day | Hepatitis B vaccination | Mean HR | CS; randomized controlled trial | 17 |
| Leite et al. [ | 29 | Brazil | 37–42 | <7 days | Heel stick | Mean HR | CS; randomized clinical trial | 17 |
| Lindh et al. [ | 25 | Sweden | 37–42 | 4-5 days | Heel stick | Mean HR, HRV | CS; observational | 11 |
| Lindh et al. [ | 28 | Sweden | 37–42 | 3 days | Venipuncture | Mean HR, HRV | CS; randomized, double-blind trial | 15 |
| Lindh et al. [ | 45 | Sweden | 37–42 | 3 months | DPT vaccination | Mean HR, HRV | CS; randomized, double-blind, controlled trial | 14 |
| Lucas-Thompson et al. [ | 49 | United States | 28–31, 32–34 | 3–5 days, 3–5 weeks | Heel stick | Mean HR | C; observational | 17 |
| Oberlander et al. [ | 23 | Canada | 37–42 | 2-3 days | Heel stick | Mean HR, HRV | CS; observational | 13 |
| Oberlander et al. [ | 22 | Canada | 37–42 | 2 months | Heel stick | Mean HR, HRV | C; observational | 13 |
| Oberlander et al. [ | 12 | Canada | 24–28 | 27–54 days | Heel stick | Mean HR, HRV | CS; observational | 11 |
| Ors et al. [ | 34 | Turkey | 37–42 | <9 days | Heel stick | HR change (%) | CS; randomized trial | 15 |
| Owens and Todt [ | 20 | United States | 37–42 | 2 days | Heel stick | Mean HR | CS; observational | 12 |
| Sajedi et al. [ | 32 | Iran | 37–42 | <1 day | Intramuscular injection | Mean HR | CS; randomized trial | 13 |
| Shibata et al. [ | 47 | Japan | 37–42 | 3-4 days | Heel stick | Mean HR | CS; observational | 14 |
| Singh et al. [ | 150 | India | 32–34, 35–37, and 37–42 | <7 days | Heel stick | Mean HR | CS; observational | 8 |
| Stevens et al. [ | 40 | Canada | 32–34 | <5 days | Heel stick | Mean HR | CS; descriptive | 15 |
| Stevens and Johnston [ | 124 | Canada | 32–34 | ≤5 days | Heel stick | Mean HR, maximum HR, and HRV | CS; observational | 17 |
| Taksande et al. [ | 80 | India | 37–42 | <7 days | Venipuncture | Mean HR | CS; observational | 11 |
| Upadhyay et al. [ | 41 | India | 37–42 | <15 days | Venipuncture | Mean HR | CS; randomized, placebo-controlled, double-blind trial | 16 |
| Uyan et al. [ | 21 | Turkey | 37–42 | <11 days | Heel stick | HR change (%), maximum HR | CS; randomized controlled trial | 14 |
| Walden et al. [ | 11 | United States | 24–26 weeks | 21 days | Heel stick | Mean HR, maximum HR | C; quasiexperimental, repeated measures | 18 |
| Weissman et al. [ | 29 | Israel | 37–42 | 2-3 days | Heel stick | HR increase (bpm), HRV | CS; randomized trial | 11 |
| Weissman et al. [ | 24 | Israel | 37–42 | 4–6 days | Heel stick | Mean HR, HRV | CS; randomized controlled trial | 10 |
Note. CS = cross-sectional study, C = cohort study. CS and C quality scores are out of 20 and 21, respectively.
Postnatal age = age at measurement.
∧Out of 20 or 21 depending on research design.
Mean and standard deviations for heart rate response to acute pain at less than 7 postnatal days.
| Gestational age | Reference | Mean HR (bpm) | SD |
|---|---|---|---|
| 25–27 weeks | Craig et al. [ | 172.38 | 17.22 |
|
| |||
| 28–32 weeks | Cong et al. [ | 165.00 | 14.00 |
| Craig et al. [ | 168.20 | 10.50 | |
| Craig et al. [ | 155.25 | 21.57 | |
| Lucas-Thompson et al. [ | 169.27 | 10.89 | |
|
| |||
| 32–34 weeks | Singh et al. [ | 183.40 | 15.93 |
| Stevens and Johnston [ | 162.20 | 15.36 | |
| Stevens et al. [ | 154.00 | 13.00 | |
| Lucas-Thompson et al. [ | 158.18 | 15.19 | |
|
| |||
| 34–37 weeks | Craig et al. [ | 163.20 | 27.82 |
| Singh et al. [ | 165.30 | 16.50 | |
|
| |||
| 37–42 weeks | Abad et al. | 170.00 | N/A |
| Craig et al. [ | 145.86 | 19.22 | |
| Campos [ | 174.00 | 16.60 | |
| Gormally et al | 180.00 | N/A | |
| Gray et al. | 123.00 | N/A | |
| Kostandy et al. | 155.00 | N/A | |
| Leite et al. [ | 172.70 | 21.50 | |
| Lindh et al. [ | 134.00 | 19.00 | |
| Lindh et al. [ | 144.00 | 20.00 | |
| Oberlander et al. | 168.00 | N/A | |
| Shibata et al. | 170.00 | N/A | |
Note. ∗ denotes numbers that were extrapolated from graphs.
Mean and standard deviations for heart rate change from baseline in response to acute pain at less than 7 postnatal days.
| Gestational age | Reference | HR change | SD |
|---|---|---|---|
| 28–32 weeks | Goubet et al. | 0–15 bpm | N/A |
|
| |||
| 37–42 weeks | Altun-Köroğlu et al. [ | 37.00% | N/A |
| Bilgen et al. [ | 19.00% | N/A | |
| Bucher et al. | 45 bpm | N/A | |
| Gray et al. [ | 36–38 bpm | N/A | |
| Haouari et al. [ | 11.40% | 3.0 | |
| Jatana et al. [ | 31.48 bpm | 6.66 bpm | |
| Ors et al. [ | 19.00% | N/A | |
| Owens and Todt [ | 49.00 bpm | 17.5 bpm | |
| Sajedi et al. [ | 10.81 | N/A | |
| Uyan et al. [ | 38.20% | N/A | |
| Weissman et al. [ | 36.50 bpm | 19.50 bpm | |
Note. ∗ denotes numbers that were extrapolated from graphs.
Mean and standard deviations for low frequency heart rate variability in response to acute pain at less than 7 postnatal days.
| Gestational age | Reference | Mean LF HRV | SD |
|---|---|---|---|
| 28–32 weeks | Cong et al. [ | 17.62 | 24.55 |
|
| |||
| 37–42 weeks | Gormally et al. | 1.65 | N/A |
| Lindh et al. [ | 4.2 | 0.4 | |
| Lindh et al. [ | 4.00 | 0.39 | |
| Oberlander et al. | 11.0 | N/A | |
| Weissman et al. [ | 1.45 | 0.38 | |
Note. HRV = heart rate variability, LF = low frequency, SD = standard deviation, and ∗ denotes numbers that were extrapolated from graphs.
Mean and standard deviations for high frequency heart rate variability in response to acute pain at less than 7 postnatal days.
| Gestational age | Reference | Mean HF HRV | SD |
|---|---|---|---|
| 28–32 weeks | Cong et al. [ | 23.52 | 35.96 |
|
| |||
| 37–42 weeks | de Oliveira et al. [ | 0.44 | 0.69 |
| Greenberg | 2.5 | N/A | |
| Lindh et al. [ | 3.4 | 0.60 | |
| Lindh et al. [ | 3.23 | 0.45 | |
| Oberlander et al. | 2.0 | N/A | |
| Weissman et al. [ | 0.76 | 0.50 | |
Note. HRV = heart rate variability, HF = high frequency, SD = standard deviation, and ∗ denotes numbers that were extrapolated from graphs.
Mean and standard deviations for low frequency/high frequency ratio in response to acute pain at less than 7 postnatal days.
| Gestational age | Reference | Mean LF/HF ratio | SD |
|---|---|---|---|
| 28–32 weeks | Cong et al. [ | 1.75 | 1.84 |
|
| |||
| 37–42 weeks | Oberlander et al. | 6.00 | N/A |
| Weissman et al. [ | 6.1 | 3.2 | |
Note. LF = low frequency, HF = high frequency, SD = standard deviation, and ∗ denotes numbers that were extrapolated from graphs.
Mean and standard deviations for total heart rate variability in response to acute pain at less than 7 postnatal days.
| Gestational age | Reference | Mean total HRV | SD |
|---|---|---|---|
| 32–34 weeks | Stevens and Johnston [ | 4.52 | 2.95 |
|
| |||
| 37–42 weeks | Lindh et al. [ | 4.30 | 0.40 |
| Lindh et al. [ | 4.10 | 0.35 | |
Note. HRV = heart rate variability, SD = standard deviation.
Mean and standard deviations for maximum heart rate in response to acute pain at less than 7 postnatal days.
| Gestational age | Reference | Maximum HR (bpm) | SD |
|---|---|---|---|
| 37–42 weeks | Campos [ | 192.00 | 11.80 |
| de Jesus et al. [ | 149.00 | N/A | |
| Owens and Todt [ | 179.40 | 13.40 | |
| Singh et al. [ | 160.30 | 20.00 | |
| Taksande et al. [ | 151.00 | 10.40 | |
| Uyan et al. [ | 186.00 | N/A |
Note. bpm = beats per minute, HR = heart rate, SD = standard deviation.
Description of study covariates included in the cardiovascular analyses.
| Study | Covariates |
|---|---|
| Abad et al. [ | N/A |
| Altun-Köroğlu et al. [ | N/A |
| Bilgen et al. [ | N/A |
| Bucher et al. [ | Sex, nurse, number of lances needed, baseline heart rate, and activity |
| Campos [ | The number of additional sticks required to obtain the blood sample, the duration of the heel stick, the frequency of crying, and the average HR |
| Cong et al. [ | N/A |
| Cong et al. [ | N/A |
| Craig et al. [ | N/A |
| de Jesus et al. [ | Gestational age, birth weight, sex, mode of delivery, diabetic mothers, breast-fed one hour before puncture, and received oral glucose |
| de Oliveira et al. [ | PIPP score in the period before the heel prick |
| Gormally et al. [ | Preintervention baseline (percentage of time crying in the last two minutes before beginning the interventions) |
| Goubet et al. [ | N/A |
| Gray et al. [ | N/A |
| Greenberg [ | Age, weight, time since last feeding, heel stick and blood collection procedure length, and gestational age |
| Grunau et al. [ | Corrected chronological age |
| Haouari et al. [ | N/A |
| Jatana et al. [ | N/A |
| Johnston et al. [ | Apgar scores at 5 minutes, gestational age at birth, time since last painful procedure, number of painful procedures since admission, or received indomethacin in the past 12 hours |
| Johnston et al. [ | Frequency of invasive procedures, severity of illness, ventilation status, and sex |
| Kostandy et al. [ | N/A |
| Leite et al. [ | N/A |
| Lindh et al. [ | N/A |
| Lindh et al. [ | N/A |
| Lindh et al. [ | N/A |
| Lucas-Thompson et al. [ | Number of prior heel sticks, duration of blood draws, sex, and baseline heart rate |
| Oberlander et al. [ | Breast-fed, SSRI exposure, age at time of acute pain, maternal analgesia, dose of SSRI at delivery, and dose of clonazepam at time of delivery |
| Oberlander et al. [ | Breast-fed, SSRI exposure, age at time of acute pain, maternal analgesia, dose of SSRI at delivery, and dose of clonazepam at time of delivery |
| Oberlander et al. [ | N/A |
| Ors et al. [ | N/A |
| Owens and Todt [ | Sex |
| Sajedi et al. [ | Sex |
| Shibata et al. [ | N/A |
| Singh et al. [ | N/A |
| Stevens et al. [ | N/A |
| Stevens and Johnston [ | N/A |
| Taksande et al. [ | N/A |
| Upadhyay et al. [ | N/A |
| Uyan et al. [ | N/A |
| Walden et al. [ | N/A |
| Weissman et al. [ | N/A |
| Weissman et al. [ | N/A |
Note. N/A = not applicable.